Axonal function in a family with episodic ataxia type 2 due to a novel mutation
Episodic ataxia type 2(EA-2) is a rare, autosomal dominantdisorder characterised by recurrentepisodes of ataxia and dysarthria,due to mutations in the CACNA1A gene on chromosome 19encoding voltage-dependent Ca 2+ channels. The aim of the presentstudy was to explore whether axonalmembrane properties,...
Gespeichert in:
Veröffentlicht in: | Journal of neurology 2008-05, Vol.255 (5), p.750-755 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Episodic ataxia type 2(EA-2) is a rare, autosomal dominantdisorder characterised by recurrentepisodes of ataxia and dysarthria,due to mutations in the
CACNA1A
gene on chromosome 19encoding voltage-dependent Ca
2+
channels. The aim of the presentstudy was to explore whether axonalmembrane properties, assessedusing nerve excitability techniques, were abnormal in patients with EA-2 . Nerve excitability techniqueswere applied to the median nerveof three individuals from threegenerations of a single family, all ofwhom had typical features of EA-2. This family was found to have anovel mutation at codon 1451 ofthe Ca
2+
channel alpha 1A subunit.Nerve excitability testing demonstratedsignificant abnormalities,with all patients outside the normal95 % confidence limits in having ahigh rheobase and reduced earlyhyperpolarizing threshold electrotonus. On average there were alsosignificant reductions in refractoriness,late subexcitability and earlydepolarizing threshold electrotonus.Mathematical modelling indicatedthat a similar pattern of abnormalitiesmay result from areduced voltage dependence ofslow K
+
channels (KCNQ channels). There are significant and distinctivechanges in peripheralnerve excitability in EA-2 patients,which are presumably induced indirectly. These findings raise thepossibility that excitability testingmay prove a convenient screeningtest for patients with this suspectedchannelopathy. |
---|---|
ISSN: | 0340-5354 1432-1459 |
DOI: | 10.1007/s00415-008-0794-x |